What is the clinical evidence from this study?

Study design: Editorial. Population: Short QT syndrome (n=29). Intervention: Implantable cardioverter-defibrillator (ICD).

September 4, 2006European Heart JournalOpen Access

Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children

View Full Paper

Ask AI

Bookmark

Key result

Short QT syndrome carries a high risk of sudden death in infants and children, making implantable cardioverter-defibrillators the therapy of choice despite technical and psychosocial challenges.

Structured PICO

Population

Editorial discussing a study of 29 patients with short QT syndrome, focusing on the risk of sudden death and the challenges of implantable cardioverter-defibrillator therapy in children.

Intervention

Implantable cardioverter-defibrillator (ICD) therapy

Limitations

Technical problems linked to small body and heart size, difficult vascular access, and the need for ongoing modifications of the implant system owing to growth
High rates of lead complications
Psychosocial acceptance of the device by the young patients and their families
Psychological distress, depression, anxiety, and poor quality of life after an ICD implant

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

While ICDs are life-saving for children with short QT syndrome, their use is complicated by technical and psychological challenges, highlighting the need for specialized care and potential pharmacological bridges like quinidine.

Cite This Study

Boriani et al. (2006) conducted an editorial in Short QT syndrome (n=29). Implantable cardioverter-defibrillator (ICD) was evaluated. Short QT syndrome carries a high risk of sudden death in infants and children, making implantable cardioverter-defibrillators the therapy of choice despite technical and psychosocial challenges.

synapsesocial.com/papers/6a6ef9d335aa2c282ce07449 https://doi.org/10.1093/eurheartj/ehl223

Topics

Cardiac device therapy

View Full Paper

Ask AI

Bookmark

Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Topics

Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children

Structured PICO

Limitations

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider